Related references
Note: Only part of the references are listed.Directed Evolution of Adeno-associated Virus for Enhanced Gene Delivery and Gene Targeting in Human Pluripotent Stem Cells
Prashanth Asuri et al.
MOLECULAR THERAPY (2012)
Enhanced Real-Time Monitoring of Adeno-Associated Virus Trafficking by Virus-Quantum Dot Conjugates
Kye-Il Joo et al.
ACS NANO (2011)
An Evolved Adeno-associated Viral Variant Enhances Gene Delivery and Gene Targeting in Neural Stem Cells
Jae-Hyung Jang et al.
MOLECULAR THERAPY (2011)
Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges
Federico Mingozzi et al.
NATURE REVIEWS GENETICS (2011)
High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency
E. Ayuso et al.
GENE THERAPY (2010)
Genome-Free Viral Capsids as Multivalent Carriers for Taxol Delivery
Wesley Wu et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
A muscle-targeting peptide displayed on AAV2 improves muscle tropism on systemic delivery
C. -Y Yu et al.
GENE THERAPY (2009)
Site-specific chemical modification of recombinant proteins produced in mammalian cells by using the genetically encoded aldehyde tag
Peng Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Unnatural amino acid incorporation into virus-like particles
Erica Strable et al.
BIOCONJUGATE CHEMISTRY (2008)
Recycling of the human prostacyclin receptor is regulated through a direct interaction with Rab11a GTPase
Katarina Wikstroem et al.
CELLULAR SIGNALLING (2008)
Visualization of targeted transduction by engineered lentiviral vectors
K-I Joo et al.
GENE THERAPY (2008)
Clinical gene therapy using recombinant adeno-associated virus vectors
C. Mueller et al.
GENE THERAPY (2008)
Treatment of Leber Congenital Amaurosis Due to RPE65 Mutations by Ocular Subretinal Injection of Adeno-Associated Virus Gene Vector: Short-Term Results of a Phase I Trial
William W. Hauswirth et al.
HUMAN GENE THERAPY (2008)
Site-specific modification of AAV vector particles with biophysical probes and targeting ligands using biotin ligase
Matthew D. Stachler et al.
MOLECULAR THERAPY (2008)
Effect of gene therapy on visual function in Leber's congenital amaurosis
James W. B. Bainbridge et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Next generation of adeno-associated virus 2 vectors: Point mutations in tyrosines lead to high-efficiency transduction at lower doses
Li Zhong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Glycerol facilitates the disaggregation of recombinant adeno-associated virus serotype 2 on mica surface
Peng Wang et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2007)
Engineering targeted viral vectors for gene therapy
Reinhard Waehler et al.
NATURE REVIEWS GENETICS (2007)
Introducing genetically encoded aldehydes into proteins
Isaac S. Carrico et al.
NATURE CHEMICAL BIOLOGY (2007)
Metabolic biotinylation provides a unique platform for the purification and targeting of multiple AAV vector serotypes
Gregory S. Arnold et al.
MOLECULAR THERAPY (2006)
Vascular bed-targeted in vivo gene delivery using tropism-modified adeno-associated viruses
LM Work et al.
MOLECULAR THERAPY (2006)
rAAV2 traffics through both the late and the recycling endosomes in a dose-dependent fashion
W Ding et al.
MOLECULAR THERAPY (2006)
Ligands for clathrin-mediated endocytosis are differentially sorted into distinct populations of early endosomes
M Lakadamyali et al.
CELL (2006)
Successful transduction of liver in hemophilia by AAV-factor IX and limitations imposed by the host immune response
CS Manno et al.
NATURE MEDICINE (2006)
Directed evolution of adeno-associated virus yields enhanced gene delivery vectors
N Maheshri et al.
NATURE BIOTECHNOLOGY (2006)
Adeno-associated virus serotypes: Vector toolkit for human gene therapy
Zhijian Wu et al.
MOLECULAR THERAPY (2006)
Identification of factors that contribute to recombinant AAV2 particle aggregation and methods to prevent its occurrence during vector purification and formulation
JF Wright et al.
MOLECULAR THERAPY (2005)
Rab7 associates with early endosomes to mediate sorting and transport of semliki forest virus to late endosomes
A Vonderheit et al.
PLOS BIOLOGY (2005)
Intracellular trafficking of adeno-associated viral vectors
W Ding et al.
GENE THERAPY (2005)
AAV hybrid serotypes: Improved vectors for gene delivery
VW Choi et al.
CURRENT GENE THERAPY (2005)
Targeted gene delivery to vascular tissue in vivo by tropism-modified adeno-associated virus vectors
SJ White et al.
CIRCULATION (2004)
Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis - A multicenter, double-blind, placebo-controlled trial
RB Moss et al.
CHEST (2004)
Endocytic recycling
FR Maxfield et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Developmentally regulated mannose 6-phosphate receptor-mediated transport of a lysosomal enzyme across the blood-brain barrier
A Urayama et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Gene therapy clinical trials worldwide 1989-2004 - an overview
ML Edelstein et al.
JOURNAL OF GENE MEDICINE (2004)
Multiple sulfatase deficiency is caused by mutations in the gene encoding the human Cα-formylglycine generating enzyme
T Dierks et al.
CELL (2003)
Deleterious effect of peptide insertions in a permissive site of the AAV2 capsid
AM Douar et al.
VIROLOGY (2003)
Differential requirements of Rab5 and Rab7 for endocytosis of influenza and other enveloped viruses
SB Sieczkarski et al.
TRAFFIC (2003)
AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B
CS Manno et al.
BLOOD (2003)
RGD inclusion in VP3 provides adeno-associated virus type 2 (AAV2)-based vectors with a heparan sulfate-independent cell entry mechanism
WF Shi et al.
MOLECULAR THERAPY (2003)
Bioconjugation by copper(I)-catalyzed azide-alkyne [3+2] cycloaddition
Q Wang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)
Quantification of adeno-associated virus particles and empty capsids by optical density measurement
JM Sommer et al.
MOLECULAR THERAPY (2003)
Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors
WF Shi et al.
HUMAN GENE THERAPY (2001)
Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells
SA Nicklin et al.
MOLECULAR THERAPY (2001)
Incorporation of tumor-targeting peptides into recombinant adeno-associated virus capsids
M Grifman et al.
MOLECULAR THERAPY (2001)
Intracellular trafficking of adeno-associated virus vectors: Routing to the late endosomal compartment and proteasome degradation
AM Douar et al.
JOURNAL OF VIROLOGY (2001)
Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors
JS Bartlett et al.
JOURNAL OF VIROLOGY (2000)
Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism
P Wu et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
